Nitric oxide-producing hydrogel materials
First Claim
1. A biocompatible, polymerizable, macromer composition comprising a macromer having at least one NO carrying region or NO modulating compound, wherein the NO or NO modulating compound is released from the macromer, and wherein the macromer further comprises one or more regions selected from the group consisting of a water soluble region, a cell adhesion ligand, and a polymerizable region.
1 Assignment
0 Petitions
Accused Products
Abstract
Hydrogels releasing or producing NO, most preferably polymerizable biodegradable hydrogels capable of releasing physiological amounts of NO for prolonged periods of time, are applied to sites on or in a patient in need of treatment thereof for disorders such as restenosis, thrombosis, asthma, wound healing, arthritis, penile erectile dysfunction or other conditions where NO plays a significant role. The polymeric materials can be formed into films, coatings, or microparticles for application to medical devices, such as stents, vascular grafts and catheters. The polymeric materials can also be applied directly to biological tissues and can be polymerized in situ. The hydrogels are formed of macromers, which preferably include biodegradable regions, and have bound thereto groups that are released in situ to elevate or otherwise modulate NO levels at the site where treatment is needed. The macromers can form a homo or hetero-dispersion or solution, which is polymerized to form a hydrogel material, that in the latter case can be a semi-interpenetrating network or interpenetrating network. Compounds to be released can be physically entrapped, covalently or ionically bound to macromer, or actually form a part of the polymeric material. The hydrogel can be formed by ionic and/or covalent crosslinking. Other active agents, including therapeutic, prophylactic, or diagnostic agents, can also be included within the polymeric material.
48 Citations
29 Claims
- 1. A biocompatible, polymerizable, macromer composition comprising a macromer having at least one NO carrying region or NO modulating compound, wherein the NO or NO modulating compound is released from the macromer, and wherein the macromer further comprises one or more regions selected from the group consisting of a water soluble region, a cell adhesion ligand, and a polymerizable region.
- 20. A method of treating a disorder or condition with NO comprising administering to an individual in need thereof a biocompatible, polymerizable, macromer composition comprising at least one NO carrying region or NO modulating compound, wherein the NO or NO modulating compound is released from the macromer composition, wherein the macromer composition comprise a macromer having regions selected from the group consisting of a water soluble region, a cell adhesion ligand, and a polymerizable region.
-
28. A method for increasing endothelial cell proliferation on a medical device comprising coating the medical device with a hydrogel coating formed from a polymerizable macromer composition comprising macromers having an NO carrying region or NO modulating compound, wheren the hydrogel coating releases NO in an amount sufficient to stimulate endothelial cell proliferation.
Specification